CDZ: Radioimmunoassay, Testosterones And Dihydrotestosterone

Product code CDZ, “Radioimmunoassay, Testosterones And Dihydrotestosterone” in FDA's classification database, is a Class I device type under 21 CFR 862.1680 (testosterone test system), reviewed by FDA's Clinical Chemistry panel. FDA's 510(k) database lists 89 clearances under CDZ, 22 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
CDZ
Regulation
21 CFR 862.1680
Class
I
Panel
Clinical Chemistry
Clearances
89
Most recent
Apr 15, 2026
Median review, last 2 years
230 days
Third-party review
Eligible
Implant
No

What it covers

A testosterone test system is a device intended to measure testosterone (a male sex hormone) in serum, plasma, and urine. Measurement of testosterone are used in the diagnosis and treatment of disorders involving the male sex hormones (androgens), including primary and secondary hypogonadism, delayed or precocious puberty, impotence in males and, in females hirsutism (excessive hair) and virilization (masculinization) due to tumors, polycystic ovaries, and adrenogenital syndromes.

The identification in 21 CFR 862.1680, testosterone test system. FDA gives CDZ no definition of its own, so the regulation’s describes it.

Recent clearances

510(k)DeviceApplicantDecisionType
K252728IDS-iSYS Total TestosteroneImmunodiagnostic Systems LimitedApr 15, 2026Traditional
K240865IDS-iSYS Free TestosteroneImmunodiagnostic Systems LimitedOct 23, 2024Traditional
K233480Access SHBGBeckman Coulter, Inc.Feb 8, 2024Traditional
K223405Access TestosteroneBeckman Coulter, Inc.Jan 13, 2023Traditional
K211685Elecsys Testosterone IIRoche DiagnosticsMay 6, 2022Traditional
K201908LIAISON Testosterone xtDiaSorin, Inc.Oct 15, 2020Special
K191350ACTIVE® Free Testosterone RIAImmunotech S.R.O.Dec 20, 2019Special
K191533ADVIA Centaur Testosterone II (TSTII), ADVIA Centaur SHBGSiemens Healthcare Diagnostics, Inc.Aug 28, 2019Traditional
K190121IDS SHBGImmunodiagnostic Systems , Ltd.Jun 17, 2019Traditional
K182521FastPack IP Sex Hormone Binding Globulin ImmunoassayQualigen, Inc.Jan 29, 2019Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 89 with a free account)

Clearances by year

22 CDZ 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)1230
20242157
2023165
20221338
2020198
20194141
20181101
20164276
20152192
20141100
20131135
20121252
20112196

Who submits

13 applicants cleared a CDZ device since 2011. 77% of the clearances went to applicants in United States, then United Kingdom (14%), Czechia (5%) and Spain (5%). By type: Traditional 86% and Special 14%.

ApplicantClearances since 2011
Siemens Healthcare Diagnostics, Inc.4
Abbott Laboratories2
Beckman Coulter, Inc.2
DiaSorin, Inc.2
Immunodiagnostic Systems Limited2
Qualigen, Inc.2
Roche Diagnostics2
Biokit, S.A.1

How FDA classifies it

Class I.

From 21 CFR 862.1680.

Standards

21 CFR 862.1680 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent CDZ clearances declared.

Ask about CDZ

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about CDZ

What is FDA product code CDZ?

Product code CDZ, “Radioimmunoassay, Testosterones And Dihydrotestosterone” in FDA's classification database, is a Class I device type under 21 CFR 862.1680 (testosterone test system), reviewed by FDA's Clinical Chemistry panel. FDA's 510(k) database lists 89 clearances under CDZ, 22 of them since 2011.

How many 510(k) clearances are there under CDZ?

FDA’s 510(k) database listed 89 clearances under CDZ as of Oct 29, 2026, 22 of them decided since 2011; the most recent decision was Apr 15, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a CDZ 510(k)?

For the 1 CDZ clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 230 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most CDZ clearances?

Since 2011: Siemens Healthcare Diagnostics, Inc. (4), Abbott Laboratories (2), Beckman Coulter, Inc. (2), DiaSorin, Inc. (2) and Immunodiagnostic Systems Limited (2). 13 applicants have cleared a CDZ device in that time.

Sources

  1. FDA product classification: CDZ · Product Classification database
  2. 21 CFR 862.1680: Testosterone test system · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for CDZ · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow CDZGet an email when FDA clears, recalls or publishes guidance for CDZ devices.

Know what FDA already cleared.